Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 08:21 am Sale |
2021-12-31 | 13G | ADMA Biologics, Inc. ADMA |
Stonepine Capital Management, LLC | 9,911,577 5.100% |
-61,300 (-0.61%) |
Filing History |
| 2022-02-11 7:47 pm Sale |
2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Stonepine Capital Management, LLC | 0 0.000% |
-3,408,849 (Position Closed) |
Filing History |
| 2022-02-11 7:26 pm Purchase |
2021-12-31 | 13G | Exagen Inc. XGN |
Stonepine Capital Management, LLC | 858,567 5.300% |
25,030 (+3.00%) |
Filing History |
| 2022-02-11 7:06 pm Purchase |
2021-12-31 | 13G | CTI BioPharma Corp. CTIC |
Stonepine Capital Management, LLC | 9,754,935 9.990% |
1,606,515 (+19.72%) |
Filing History |
| 2022-02-11 7:03 pm Purchase |
2021-12-31 | 13G | Apollo Endosurgery, Inc. APEN |
Stonepine Capital Management, LLC | 2,655,129 6.500% |
51,649 (+1.98%) |
Filing History |
| 2022-02-11 6:45 pm Purchase |
2021-12-31 | 13G | Rezolute, Inc. RZLT |
Stonepine Capital Management, LLC | 808,405 5.200% |
19,079 (+2.42%) |
Filing History |
| 2022-02-11 6:24 pm Purchase |
2021-12-31 | 13G | Conformis, Inc. CFMS |
Stonepine Capital Management, LLC | 590,753 7.900% |
224,278 (+61.20%) |
Filing History |
| 2022-02-11 6:22 pm Sale |
2021-12-31 | 13G | Yumanity Therapeutics, Inc. YMTX |
Stonepine Capital Management, LLC | 0 0.000% |
-91,946 (Position Closed) |
Filing History |
| 2022-02-11 5:55 pm Sale |
2021-12-31 | 13G | Catalyst Biosciences, Inc. CBIO |
Stonepine Capital Management, LLC | 0 0.000% |
-543,781 (Position Closed) |
Filing History |
| 2022-02-11 5:47 pm Purchase |
2021-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Stonepine Capital Management, LLC | 4,006,185 5.900% |
506,185 (+14.46%) |
Filing History |
| 2022-02-11 5:45 pm Sale |
2021-12-31 | 13G | SCYNEXIS, Inc. SCYX |
Stonepine Capital Management, LLC | 385,650 1.600% |
-1,145,000 (-74.80%) |
Filing History |
| 2022-02-11 3:32 pm Sale |
2021-12-31 | 13G | Applied Genetic Technologies Corporation AGTC |
Stonepine Capital Management, LLC | 0 0.000% |
-2,273,876 (Position Closed) |
Filing History |
| 2022-02-11 3:29 pm Sale |
2021-12-31 | 13G | Aytu BioPharma, Inc. AYTU |
Stonepine Capital Management, LLC | 0 0.000% |
-27,975,520 (Position Closed) |
Filing History |
| 2022-02-11 2:27 pm Purchase |
2021-12-31 | 13G | Amryt Pharma plc AMYT |
Stonepine Capital Management, LLC | 30,348,875 9.500% |
19,266,460 (+173.85%) |
Filing History |
| 2022-02-11 2:17 pm Purchase |
2021-12-31 | 13G | DiaMedica Therapeutics Inc. DMAC |
Stonepine Capital Management, LLC | 1,394,929 5.300% |
244,670 (+21.27%) |
Filing History |
| 2022-01-13 6:13 pm Purchase |
2022-01-07 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Stonepine Capital Management, LLC | 6,491,099 5.200% |
6,491,099 (New Position) |
Filing History |
| 2021-12-30 12:26 pm Purchase |
2021-12-28 | 13G | ADMA Biologics, Inc. ADMA |
Stonepine Capital Management, LLC | 9,972,877 5.100% |
9,972,877 (New Position) |
Filing History |
| 2021-12-23 5:34 pm Purchase |
2021-12-21 | 13G | Rezolute, Inc. RZLT |
Stonepine Capital Management, LLC | 789,326 5.100% |
789,326 (New Position) |
Filing History |
| 2021-12-23 5:33 pm Purchase |
2021-12-20 | 13G | Exagen Inc. XGN |
Stonepine Capital Management, LLC | 833,537 5.200% |
833,537 (New Position) |
Filing History |
| 2021-11-19 4:55 pm Purchase |
2021-11-10 | 13G | Yumanity Therapeutics, Inc. YMTX |
Stonepine Capital Management, LLC | 91,946 6.200% |
91,946 (New Position) |
Filing History |